| Fondaparinux, Arixtra
Fondaparinux is a synthetic and specific inhibitor of activated Factor X (Xa).
inhibits Factor X
ARIXTRA Injection is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism:
¥ in patients undergoing hip fracture surgery, including extended prophylaxis;
¥ in patients undergoing hip replacement surgery;
¥ in patients undergoing knee replacement surgery;
¥ in patients undergoing abdominal surgery who are at risk for thromboembolic complications.
ARIXTRA Injection is indicated for:
¥ the treatment of acute deep vein thrombosis when administered in conjunction with warfarin sodium, and
¥ the treatment of acute pulmonary embolism when administered in conjunction with warfarin sodium when initial therapy is administered in the hospital.
Hemorrhage: During ARIXTRA administration, the most common adverse reactions were bleeding complications
Elevations of Serum Aminotransferases
Fantastic new books!
Complementary and Alternative Medical Lab Testing is chock full of references for over 100 diseases.
Nutritional Genetics is also a referenced resource with sections on over 100 diseases.
Great Health Quotes has wonderful quotations about health, healing, disease, doctors, and medicine, and it's FREE.
A Brief Introduction to Naturopathy and Naturopathic Medicine describes the history and modalities. It's also FREE.